Sort
82,697 grants matching “vaccine development”
Rational design and targeted selection of DNA-scaffolded nicotine vaccines
$1,253,672Yung Chang · Arizona State University-Tempe Campus · R01 · FY2015 · DA
Therapeutic Monoclonal Antibodies to H5N1 Influenza
$1,253,062Richard John Webby · St. Jude Children'S Research Hospital · U01 · FY2006 · AI
Primary Administrative Core
$1,252,705Philip Frederick Sparling · Univ Of North Carolina Chapel Hill · U54 · FY2008 · AI
Predicting immune responses that correlate with protection against tuberculosis
$1,252,487Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · HL
ESTABLISHMENT OF SPECIFIC PATHOGEN FREE RHESUS AND PIGTA
$1,252,364Oregon Health And Science University · U24 · FY2004 · RR
Enhancing immunity to malaria in young children with effective chemoprevention
$1,252,084Prasanna Jagannathan · Stanford University · U01 · FY2023 · AI
Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy
$1,252,072Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Host Immune Responses to Antigens of Malaria Parasites
$1,252,048Carole Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Units for HIV/AIDS Clinical Trials Networks
$1,251,667Ram Yogev · Lurie Children'S Hospital Of Chicago · U01 · FY2009 · AI
Development of a novel adjuvant for vaccine sparing
$1,250,865Sara Lustigman · New York Blood Center · R01 · FY2016 · AI
Mechanisms of naturally-acquired immunity to malaria
$1,250,595Peter Crompton · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
India International Center for Excellence in Research
$1,250,220Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Delaware Valley Node of the Clinical Trials Network
$1,250,000George E Woody · University Of Pennsylvania · U10 · FY2007 · DA
Research on the Epidemiology,Prevention,Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa.09
$1,250,000Cheryl Cohen · National Health Laboratory Service · U01 · FY2019 · IP
Clinical Trials Network: Long Island Regional Node
$1,250,000Edward V Nunes · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · U10 · FY2007 · DA
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses
$1,250,000Adriana H Tremoulet · University Of California, San Diego · P50 · FY2021 · HD
Seasonal Influenza Vaccine Effectiveness in a Tropical Developing African Country
$1,250,000John Christian Victor · Path · U01 · FY2013 · IP
NINDS/UC Davis NeuroMab Hybridoma Facility
$1,250,000James S Trimmer · University Of California At Davis · U24 · FY2008 · NS
Seasonal Influenza Vaccine Effectiveness in a Tropical Developing African Country
$1,250,000John Christian Victor · Path · U01 · FY2012 · IP
Delaware Valley Node of the Clinical Trials Network
$1,250,000George E Woody · University Of Pennsylvania · U10 · FY2008 · DA
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses
$1,250,000Adriana H Tremoulet · University Of California, San Diego · P50 · FY2022 · HD
Exposure to PFNA and other PFAS in drinking water and associations with health-related outcomes in Gloucester County NJ
$1,249,999Robert John Laumbach · Rbhs-School Of Public Health · U01 · FY2022 · TS
AD04 disease-modifying drug for Alzheimer's - preclinical and IND-enabling studies
$1,249,957Carmela R Abraham · Advantage Therapeutics, Inc · R44 · FY2025 · AG
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities
$1,249,833Anice Lowen · Emory University · N01 · FY2024 · AI
Vaccine and Treatment Evaluation Units: Protocol Development and Implementation of a Natural History Challenge Study for Influenza
$1,249,595Robert Frenck · Cincinnati Childrens Hosp Med Ctr · N01 · FY2019 · AI